{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:56:10Z","timestamp":1790402170718,"version":"4.1.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":643,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo Co., Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Atrial fibrillation (AF) and heart failure (HF) often coexist. Older age is strongly associated with stroke, HF, and mortality. The association between coexistence of HF and a risk of clinical outcomes and the effectiveness of anticoagulation therapy including direct oral anticoagulants (DOACs) in elderly patients with AF and HF have not been investigated. We aimed to evaluate 2 years of outcomes and to elucidate the efficacy of DOACs or warfarin in elderly AF patients in the All Nippon AF In the Elderly (ANAFIE) Registry with and without a history of HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>The ANAFIE Registry is a multicentre, prospective observational study following elderly non-valvular AF patients aged \u226575 years for 2 years. Hazard ratios (HRs) were calculated based on the presence or absence of an HF diagnosis and DOAC or warfarin use at enrolment. Among 32 275 eligible patients, 12 116 (37.5%) had been diagnosed with HF. Patients with HF had significantly higher rates of HF hospitalization or cardiovascular death (HR 1.94, P &amp;lt; 0.001), cardiovascular events (HR 1.59, P &amp;lt; 0.001), cardiovascular death (HR 1.49, P &amp;lt; 0.001), all-cause death (HR 1.32, P &amp;lt; 0.001), and net clinical outcome including stroke\/systemic embolism, major bleeding, and all-cause death (HR 1.23, P &amp;lt; 0.001), compared with those without HF; however, HRs for stroke\/systemic embolism (HR 0.96, P = 0.56) and major bleeding (HR 1.14, P = 0.13) were similar. DOAC use was associated with a low risk of stroke\/systemic embolism (HR 0.86, P = 0.19 in HF; HR 0.79, P = 0.016 in non-HF; P for interaction = 0.56), major bleeding (HR 0.71, P = 0.008 in HF; HR 0.75, P = 0.016 in non-HF; P for interaction = 0.74), HF hospitalization or cardiovascular death (HR 0.81, P &amp;lt; 0.001 in HF; HR 0.78, P &amp;lt; 0.001 in non-HF; P for interaction = 0.26), cardiovascular events (HR 0.83, P &amp;lt; 0.001 in HF; HR 0.82, P = 0.001 in non-HF; P for interaction = 0.65), cardiovascular death (HR 0.84, P = 0.12 in HF; HR 0.75, P = 0.035 in non-HF; P for interaction = 0.18), all-cause death (HR 0.89, P = 0.082 in HF; HR 0.80, P = 0.001 in non-HF; P for interaction = 0.091), and net clinical outcome (HR 0.88, P = 0.019 in HF; HR 0.81, P &amp;lt; 0.001 in non-HF; P for interaction = 0.21) compared with warfarin, irrespective of the presence or absence of HF. Analysis using the propensity score matching method showed similar associations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Non-valvular AF patients aged \u226575 years with a history of HF had higher risks of cardiovascular events and mortality. DOACs were favourable to warfarin regardless of the coexistence of HF. These results might encourage the use of DOACs in elderly patients with non-valvular AF with or without HF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14550","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T02:20:21Z","timestamp":1705026021000},"page":"902-913","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Clinical Outcomes and Anticoagulation Therapy in Elderly Non-Valvular Atrial Fibrillation and Heart Failure Patients"],"prefix":"10.1093","volume":"11","author":[{"given":"Shota","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University , 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Hiasa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University , 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Inoue","sequence":"additional","affiliation":[{"name":"Saiseikai Toyama Hospital , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Cardiovascular Institute , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Akao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kyoto Medical Center , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Atarashi","sequence":"additional","affiliation":[{"name":"AOI Hachioji Hospital , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Koretsune","sequence":"additional","affiliation":[{"name":"Institute for Clinical Research, National Hospital Organization Osaka National Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Okumura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center , Kumamoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, Nippon Medical School , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Cardiovascular Institute , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Toho University Faculty of Medicine , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Hirayama","sequence":"additional","affiliation":[{"name":"Osaka Police Hospital , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yasaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine and Neurology, Cerebrovascular Center, National Hospital Organization Kyushu Medical Center , Fukuoka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Yamaguchi","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center , Osaka ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Teramukai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine , Kyoto ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Morishima","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Daiichi Sankyo Co., Ltd. , Tokyo ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medical Sciences, Kyushu University , 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"2026012113161432200_ehf214550-bib-0001","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10741-011-9290-y","article-title":"Atrial fibrillation and heart failure in the elderly","volume":"17","author":"Kazemian","year":"2012","journal-title":"Heart Fail Rev"},{"key":"2026012113161432200_ehf214550-bib-0002","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCHEARTFAILURE.112.000143","article-title":"Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: Insights from the ARISTOTLE trial","volume":"6","author":"McMurray","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0003","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.113.000212","article-title":"Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation insights from ROCKET AF","volume":"6","author":"van Diepen","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0004","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ejhf.595","article-title":"Efficacy and safety of edoxaban compared with warfarin in patients with atrial fibrillation and heart failure: Insights from ENGAGE AF-TIMI 48","volume":"18","author":"Magnani","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0005","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/eurjhf\/hft111","article-title":"Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: A subgroup analysis of the RE-LY trial","volume":"15","author":"Ferreira","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0006","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.jacc.2010.05.028","article-title":"Age as a risk factor for stroke in atrial fibrillation patients: Implications for thromboprophylaxis","volume":"56","author":"Marinigh","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"2026012113161432200_ehf214550-bib-0007","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2147\/CIA.S302389","article-title":"Age-related clinical outcomes of patients with non-valvular atrial fibrillation: Insights from the COOL-AF registry","volume":"16","author":"Krittayaphong","year":"2021","journal-title":"Clin Interv Aging"},{"key":"2026012113161432200_ehf214550-bib-0008","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j5058","article-title":"Oral anticoagulants for prevention of stroke in atrial fibrillation: Systematic review, network meta-analysis, and cost effectiveness analysis","volume":"359","author":"L\u00f3pez-L\u00f3pez","year":"2017","journal-title":"BMJ"},{"key":"2026012113161432200_ehf214550-bib-0009","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","article-title":"Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: Patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex","volume":"145","author":"Carnicelli","year":"2022","journal-title":"Circulation"},{"key":"2026012113161432200_ehf214550-bib-0010","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrneph.2016.113","article-title":"Heart failure and kidney dysfunction: Epidemiology, mechanisms and management","volume":"12","author":"Schefold","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"2026012113161432200_ehf214550-bib-0011","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jacep.2015.02.019","article-title":"Age-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe","volume":"1","author":"Fumagalli","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012113161432200_ehf214550-bib-0012","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/ehf2.13156","article-title":"Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF","volume":"8","author":"Ambrosio","year":"2021","journal-title":"ESC Hear Fail"},{"key":"2026012113161432200_ehf214550-bib-0013","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ehjqcco\/qcab025","article-title":"Two-year outcomes of more than 30 000 elderly patients with atrial fibrillation: Results from the All Nippon AF In the Elderly (ANAFIE) Registry","volume":"8","author":"Yamashita","year":"2022","journal-title":"Eur Hear J Qual Care Clin Outcomes"},{"key":"2026012113161432200_ehf214550-bib-0014","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jjcc.2018.02.018","article-title":"Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry","volume":"72","author":"Inoue","year":"2018","journal-title":"J Cardiol"},{"key":"2026012113161432200_ehf214550-bib-0015","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1253\/circj.CJ-19-0342","article-title":"JCS 2017\/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure\u2014Digest version","volume":"2019","author":"Tsutsui","journal-title":"Circ J"},{"key":"2026012113161432200_ehf214550-bib-0016","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012113161432200_ehf214550-bib-0017","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","article-title":"2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"2026012113161432200_ehf214550-bib-0018","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1002\/ehf2.13922","article-title":"Baseline characteristics of 547 new onset heart failure patients in the PREFERS heart failure study","volume":"9","author":"Linde","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0019","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: Temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026012113161432200_ehf214550-bib-0020","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1161\/CIRCULATIONAHA.108.816082","article-title":"Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study","volume":"119","author":"Go","year":"2009","journal-title":"Circulation"},{"key":"2026012113161432200_ehf214550-bib-0021","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1056\/NEJMoa1105594","article-title":"Stroke and bleeding in atrial fibrillation with chronic kidney disease","volume":"367","author":"Olesen","year":"2012","journal-title":"N Engl J Med"},{"key":"2026012113161432200_ehf214550-bib-0022","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1093\/europace\/euz292","article-title":"The association between patterns of atrial fibrillation, anticoagulation, and cardiovascular events","volume":"22","author":"Atar","year":"2020","journal-title":"Europace"},{"key":"2026012113161432200_ehf214550-bib-0023","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1253\/circj.CJ-18-0872","article-title":"Current status, time trends and outcomes of combination therapy with oral anticoagulant and antiplatelet drug in patients with atrial fibrillation\u2014The Fushimi AF registry","volume":"82","author":"Masunaga","year":"2018","journal-title":"Circ J"},{"key":"2026012113161432200_ehf214550-bib-0024","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13745","article-title":"Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry","volume":"52","author":"Ding","year":"2022","journal-title":"Eur J Clin Invet"},{"key":"2026012113161432200_ehf214550-bib-0025","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ijcard.2015.10.220","article-title":"Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes","volume":"203","author":"Kotecha","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026012113161432200_ehf214550-bib-0026","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.116.004267","article-title":"Stroke and mortality risk in patients with various patterns of atrial fibrillation: Results from the ENGAGE AF-TIMI 48 trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)","volume":"10","author":"Link","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026012113161432200_ehf214550-bib-0027","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1093\/ehjcvp\/pvab044","article-title":"Antiplatelet therapy in patients with atrial fibrillation: A systematic review and meta-analysis of randomized trials","volume":"29","author":"Benz","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026012113161432200_ehf214550-bib-0028","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1177\/2047487320960288","article-title":"Role of comorbidities in heart failure prognosis part I: Anaemia, iron deficiency, diabetes, atrial fibrillation","volume":"27","author":"Paolillo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026012113161432200_ehf214550-bib-0029","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1093\/cvr\/cvaa263","article-title":"Pleiotropic actions of factor Xa inhibition in cardiovascular prevention: Mechanistic insights and implications for anti-thrombotic treatment","volume":"117","author":"Cate","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026012113161432200_ehf214550-bib-0030","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/jpet.112.194837","article-title":"The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice","volume":"343","author":"Lee","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"2026012113161432200_ehf214550-bib-0031","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/432080","article-title":"Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban","volume":"2011","author":"Zhou","year":"2011","journal-title":"Mediators Inflamm"},{"key":"2026012113161432200_ehf214550-bib-0032","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.jacbts.2016.05.002","article-title":"Direct thrombin inhibitors prevent left atrial remodeling associated with heart failure in rats","volume":"1","author":"Jumeau","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"2026012113161432200_ehf214550-bib-0033","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1253\/circj.CJ-21-0180","article-title":"Echocardiographic structure and function in elderly patients with atrial fibrillation in Japan\u2014The ANAFIE Echocardiographic Substudy","volume":"86","author":"Hiasa","year":"2022","journal-title":"Circ J"},{"key":"2026012113161432200_ehf214550-bib-0034","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.949726","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with heart failure and preserved, mildly reduced, and reduced ejection fraction: A systemic review and meta-analysis","volume":"9","author":"Wulamiding","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"2026012113161432200_ehf214550-bib-0035","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/ehf2.13905","article-title":"Sodium-glucose cotransporter-2 inhibitors in heart failure: An updated meta-analysis","volume":"9","author":"Cao","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026012113161432200_ehf214550-bib-0036","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/ehf2.13313","article-title":"SGLT2i versus ARNI in heart failure with reduced ejection fraction: A systematic review and meta-analysis","volume":"8","author":"Yan","year":"2021","journal-title":"ESC Heart Fail"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/902\/64540391\/eschf_11_2_902.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/902\/64540391\/eschf_11_2_902.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:18:11Z","timestamp":1769019491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/2\/902\/8271375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14550","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"2023-01-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}